The Mechanical Ventilator Milano design helps overcome the ventilator shortage, aids with the respiratory effects of the pandemic. Credit: MVM Collaboration WASHINGTON, March 23, 2021 —...
AstraZeneca just announced results from its US-based trial. It found the vaccine to be 79% effective and safe for use, despite recent concerns around reports of...
Ocugen (OCGN) has been one of 2021’s biggest and unlikeliest success stories. The eye disease specialist has shifted its focus to getting another Covid-19 vaccine to market.\
AstraZeneca’s Covid-19 vaccine performed better than expected in a major late-stage trial, potentially paving the way for its emergency authorization in the United States and bolstering...
The savvy investor knows that the best time to buy is when a stock is priced low – it’s just the old game of ‘buy low...
Scientists are exploring several possibilities that might explain at least 18 reports of extremely rare blood clots in the brain that occurred in individuals in the...
Johnson & Johnson is developing several next generation Covid-19 vaccines against the emerging variants of the coronavirus, Chief Executive Officer Alex Gorsky said on March 18.
So far, most vaccines in the US are mRNA vaccines. These represent a new technology and are likely to take over the vaccine world. But how...
Shares of GenMark Diagnostics soared in trading on March 15 after Roche announced the acquisition of the California-based company in a $1.8 billion deal to bolster...
Johnson & Johnson’s single-dose COVID-19 vaccine, which was developed by the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen), has been issued an Emergency Use Listing...
CDC Vs. Common Sense Authored by Peter Alexander via The American Institute for Economic Research, The death of Common Sense begins with the words initiated by...
Genentech reported that the company's rheumatoid arthritis drug Actemra failed to hit the primary endpoint in a Covid-19 trial, while Vir and GlaxoSmithKline’s antibody against Covid-19...
The stock market has been pulled aggressively in both directions in 2021, but the moves are relatively tame compared to the wild ride of Vaxart (VXRT)...
Vir and GSK plan to seek emergency use authorization for their experimental Covid-19 antibody therapy after interim data from a study showed 85 percent reduction in...
Europe’s drug regulator said on March 11 it had initiated a rolling review of U.S.-based Eli Lilly’s antibodies to treat Covid-19, days after saying their combination...
Newly announced data from Eli Lilly’s Phase III BLAZE-1 clinical trial show a combination of two of the company’s monoclonal antibodies, bamlanivimab (LY-CoV555) and etesevimab (LY-CoV016),...
In a recent note on the state of the stock markets, Raymond James equity strategist Tavis McCourt points out a series of policy factors that are...
The EMA’s human medicines committee has said two Eli Lilly antibodies are effective in people with COVID-19 with severe risk.
Abbott’s Alinity m Resp-4-Plex molecular assay, which was designed to test for four viruses in one test, has been authorized for emergency use by the US...
'Fear' Is The New 'Smart' Authored by Raul Ilargi Meijer via The Automatic Earth blog, The Washington Post said recently: “The anti-vaccine movement is comparable to domestic...
The U.S. health regulator granted emergency use authorization for Abbott Laboratories' molecular test to detect and distinguish the coronavirus and two types of flu viruses with...
CureVac NV inked a deal with Switzerland’s Novartis AG to manufacture the German biopharmaceutical company’s Covid-19 vaccine candidate, CVnCoV.
3 Penny Stocks To Watch Before Next Week The post Best Penny Stocks To Watch Right Now As Markets Attempt To Rebound appeared first on Penny...
Ocugen (OCGN) is a latecomer to the coronavirus stock party. But in true latecomer fashion, it has made a dazzling entrance. Shares are up year-to-date by...
Novavax hopes its COVID-19 vaccine could be filed in the US in the second quarter, following a potential green light for the vaccine in May
Novavax Chief Executive Officer Stanley Erck believes the U.S. Food and Drug Administration could grant Emergency Use Authorization (EUA) for the company's Covid-19 vaccine by May.
Moderna (MRNA) has been one the past year’s most successful stories. The change between the high-flying biotech’s standing a year ago compared to its current position,...
How Does The J&J Vaccine Compare To Other COVID Vaccines? 4 Questions Answered Authored by Yves Smith via NakedCapitalism.com, We are running this post for one...
Johnson & Johnson’s newly authorized Covid-19 vaccine started shipping and the company's top executive said on March 1 that Americans should be able to receive the...
There is still no cure for COVID-19, but doctors have several innovative treatments. Some are keeping patients out of the hospital entirely.